Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Showing 1 to 12 of 811 entries
Sorted by: Best Match Show Resources per page
[The use of T-activin for the prevention of congenital influenzal infection in mice and the correction of the immune deficiency].

Zhurnal mikrobiologii, epidemiologii i immunobiologii

Mirchink EP, Pronin AV, Arion VIa, Deeva AV, Zimina IV, Zuev VA.
PMID: 2385991
Zh Mikrobiol Epidemiol Immunobiol. 1990 Apr;(4):60-4.

Viremia accompanying influenza infection and the possibility of transplacental passage of the virus into the fetus make it expedient to develop measures for the prophylaxis of intrauterine infection of the fetus in case of influenza during pregnancy. The work...

ASHP therapeutic guidelines for intravenous immune globulin. ASHP Commission on Therapeutics.

Clinical pharmacy

[No authors listed]
PMID: 1312920
Clin Pharm. 1992 Feb;11(2):117-36.

No abstract available.

[Treatment of immunodeficient conditions caused by viral infection with the Soviet immunomodulator kemantan in patients with pulmonary tuberculosis].

Problemy tuberkuleza

Kossii NV, Khomenko IS, Gergert VIa.
PMID: 1780303
Probl Tuberk. 1991;(6):23-6.

Observation of 219 patients with pulmonary tuberculosis was made to study the effect of acute respiratory viral infection (ARVI) on the course of the disease. The affected were divided into 2 groups: 136 subjects who had ARVI and 83...

[Clinical use of colony-stimulating factors].

Vestnik Akademii meditsinskikh nauk SSSR

Tiuliandin SA, Garin AM.
PMID: 2192516
Vestn Akad Med Nauk SSSR. 1990;(2):54-8.

No abstract available.

[Adoptive and immunostimulating therapy in patients with a deficit of immunoactive lymphocytes].

Vrachebnoe delo

Antonenko VT, Polinkevich BS, Iusubov IuA, Kucher II.
PMID: 855280
Vrach Delo. 1977 Mar;(3):145-8.

No abstract available.

[Levamisole as an immunostimulant].

Orvosi hetilap

Pár A.
PMID: 882260
Orv Hetil. 1977 Jul 24;118(30):1759-62.

No abstract available.

Reconstitution of T-cell deficiency by thymic hormone or thymus transplantation therapy.

Clinical immunology and immunopathology

Hong R.
PMID: 3521966
Clin Immunol Immunopathol. 1986 Jul;40(1):136-41. doi: 10.1016/0090-1229(86)90077-2.

Correction of T-cell defects by either thymic hormone treatment or thymus transplantation has proven to be more difficult clinically than historically anticipated. Because the precise action of thymic hormones is unknown and because these hormones act upon post-thymic cells,...

Effects of escalating doses of recombinant human interleukin-2 in correcting functional T-cell defects following autologous bone marrow transplantation for lymphomas and solid tumors.

Experimental hematology

Bosly A, Guillaume T, Brice P, Humblet Y, Staquet P, Doyen C, Chatelain B, Franks CR, Gisselbrecht C, Symann M.
PMID: 1354620
Exp Hematol. 1992 Sep;20(8):962-8.

High-dose chemotherapy followed by autologous bone marrow transplantation (ABMT) in the treatment of malignancies is often associated with immune deficiency following transplantation, possibly contributing to tumor relapse or fatal infection. Interleukin 2 (IL-2), which enhances major histocompatibility complex (MHC)-unrestricted...

Results in two infants with the DiGeorge syndrome--effects of long-term TP5.

Clinical immunology and immunopathology

Businco L, Rubaltelli FF, Paganelli R, Galli E, Ensoli B, Betti P, Aiuti F.
PMID: 3084141
Clin Immunol Immunopathol. 1986 May;39(2):222-30. doi: 10.1016/0090-1229(86)90086-3.

We treated two patients affected by DiGeorge syndrome with long-term administration of the synthetic thymic hormone thymopoietin (TP5). In both cases we obtained durable immunological reconstitution, starting as early as 2 weeks after beginning of TP5 treatment. High levels...

[Therapy of immunologic deficiencies in children].

Deutsche medizinische Wochenschrift (1946)

Oehme J, Ritter J.
PMID: 1091432
Dtsch Med Wochenschr. 1975 Mar 21;100(12):624-5. doi: 10.1055/s-0028-1106270.

No abstract available.

Immune dysfunction in hypophosphatemic vitamin D-resistant rickets: immunoregulatory reaction of 1 alpha(OH) vitamin D3.

Clinical immunology and immunopathology

Kitajima I, Maruyama I, Matsubara H, Osame M, Igata A.
PMID: 2548783
Clin Immunol Immunopathol. 1989 Oct;53(1):24-31. doi: 10.1016/0090-1229(89)90097-4.

We investigated immunologic function in six cases with hypophosphatemic vitamin D-resistant rickets (VDRR) before and after treatment with 1 alpha-hydroxycholecalciferol (1 alpha(OH) vitamin D3). All cases suffered frequent episodes of infection, which tended to be more severe in the...

[Immunomodulator therapy with cimetidine in patients with common variable immunodeficiency].

Revista paulista de medicina

Naspitz CK, Sole D, Leser PG.
PMID: 2963364
Rev Paul Med. 1987 Jan-Feb;105(1):47-50.

No abstract available.

Showing 1 to 12 of 811 entries